Insider · CIK 0001262327
Augustine Lawlor
Files at CYPH (LEAP THERAPEUTICS, INC.). First filing -, latest -.
In brief
Augustine Lawlor files SEC Form 4 as COO at CYPH (LEAP THERAPEUTICS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Augustine Lawlor has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 28, 2025 | CYPH LEAP THERAPEUTICS, INC. | MOption exercise Common Stock | +22,500 | - | - | 27,586 | Apr 1, 2025 |
| Mar 28, 2025 | CYPH LEAP THERAPEUTICS, INC. | FTax withholding Common Stock | -7,797 | $0.32 | $2,469 | 19,789 | Apr 1, 2025 |
| Mar 28, 2025 | CYPH LEAP THERAPEUTICS, INC. | MOption exercise Restricted Stock Unitsderivative | -22,500 | $0.00 | $0 | 0 | Apr 1, 2025 |
| Nov 13, 2024 | CYPH LEAP THERAPEUTICS, INC. | XIn-the-money exercise Common Stockindirect: See Footnotes | +2,136 | $2.82 | $6,024 | 678,456 | Nov 15, 2024 |
| Nov 13, 2024 | CYPH LEAP THERAPEUTICS, INC. | XIn-the-money exercise Warrant (Right to Buy)derivativeindirect: See Footnote | -2,136 | $0.00 | $0 | 0 | Nov 15, 2024 |
| Oct 2, 2024 | CYPH LEAP THERAPEUTICS, INC. | AGrant or award Employee Stock Option (Right to Buy)derivative | +85,000 | $0.00 | $0 | 85,000 | Oct 4, 2024 |
| Jan 29, 2024 | CYPH LEAP THERAPEUTICS, INC. | AGrant or award Employee Stock Option (Right to Buy)derivative | +85,000 | $0.00 | $0 | 85,000 | Jan 31, 2024 |
| Jan 26, 2024 | CYPH LEAP THERAPEUTICS, INC. | MOption exercise Common Stock | +5,000 | - | - | 5,086 | Jan 30, 2024 |
| Jan 26, 2024 | CYPH LEAP THERAPEUTICS, INC. | MOption exercise Restricted Stock Unitsderivative | -5,000 | $0.00 | $0 | 0 | Jan 30, 2024 |
Questions about Augustine Lawlor
Answered from the filings on this page, as of the latest one.
Is Augustine Lawlor buying or selling?
Augustine Lawlor has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Augustine Lawlor's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Augustine Lawlor has 0.
Where does Augustine Lawlor file Form 4?
Augustine Lawlor has filed Form 4 at CYPH (LEAP THERAPEUTICS, INC.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.